Xenex
Hospitals and Health CareTexas, United States51-200 Employees
Xenex is setting a higher standard for microbial reduction. Our mission is to save lives and reduce suffering by destroying the deadly microorganisms that cause infections.
Innovation Leadership Xenex has established itself as a pioneer in UV disinfection technology with flagship products like LightStrike 2.0 and TrackMate, demonstrating a continuous commitment to innovation that can attract healthcare providers seeking cutting-edge infection control solutions.
Recent Technology Launches The company's recent launches of TrackMate and upgraded UV disinfection robots suggest opportunities to expand product adoption in hospitals prioritizing automated and trackable disinfection processes, aligning with the latest healthcare standards.
Market Recognition Being named the 2020 Global Company of the Year highlights Xenex’s credibility and leadership in the infection prevention space, making it an attractive partner for hospitals and healthcare networks aiming to improve patient safety.
Financial Capacity With substantial funding of $85 million and revenues between $25 million and $50 million, Xenex possesses the financial strength to support expansion, ongoing R&D, and large-scale implementations in hospital systems across regions.
Strategic Growth Potential Xenex’s focus on healthcare-specific disinfection innovations and recent technological advances position it well for strategic partnerships and sales opportunities with hospital chains looking to enhance infection control protocols and meet evolving regulatory demands.
Xenex uses 8 technology products and services including Crazy Egg, WordPress Super Cache, jsDelivr, and more. Explore Xenex's tech stack below.
| Xenex Email Formats | Percentage |
| First.Last@xenex.com | 90% |
| FLast@xenex.com | 6% |
| FirstLast@xenex.com | 3% |
| First_Last@xenex.com | 1% |
Hospitals and Health CareTexas, United States51-200 Employees
Xenex is setting a higher standard for microbial reduction. Our mission is to save lives and reduce suffering by destroying the deadly microorganisms that cause infections.
Xenex has raised a total of $85M of funding over 3 rounds. Their latest funding round was raised on Oct 02, 2018 in the amount of $4.8Mas a debt financing.
Xenex's revenue is estimated to be in the range of $25M$50M
Xenex has raised a total of $85M of funding over 3 rounds. Their latest funding round was raised on Oct 02, 2018 in the amount of $4.8Mas a debt financing.
Xenex's revenue is estimated to be in the range of $25M$50M